ATE464874T1 - Verfahren zur verwendung von fet-etikettierten oligonukleotiden mit 3',5' exonukleasenresistenter quenchdomäne und zusammensetzungen zur ausübung davon - Google Patents

Verfahren zur verwendung von fet-etikettierten oligonukleotiden mit 3',5' exonukleasenresistenter quenchdomäne und zusammensetzungen zur ausübung davon

Info

Publication number
ATE464874T1
ATE464874T1 AT08153863T AT08153863T ATE464874T1 AT E464874 T1 ATE464874 T1 AT E464874T1 AT 08153863 T AT08153863 T AT 08153863T AT 08153863 T AT08153863 T AT 08153863T AT E464874 T1 ATE464874 T1 AT E464874T1
Authority
AT
Austria
Prior art keywords
fet
compositions
quenchdomain
labled
exercising
Prior art date
Application number
AT08153863T
Other languages
English (en)
Inventor
Quin Chou
Jr Cirilo D Cabradilla
Dragan Spasic
Original Assignee
Life Technologies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27753904&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE464874(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Life Technologies Corp filed Critical Life Technologies Corp
Application granted granted Critical
Publication of ATE464874T1 publication Critical patent/ATE464874T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C12Q1/6825—Nucleic acid detection involving sensors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT08153863T 2002-02-27 2003-02-25 Verfahren zur verwendung von fet-etikettierten oligonukleotiden mit 3',5' exonukleasenresistenter quenchdomäne und zusammensetzungen zur ausübung davon ATE464874T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/087,229 US6818420B2 (en) 2002-02-27 2002-02-27 Methods of using FET labeled oligonucleotides that include a 3′-5′ exonuclease resistant quencher domain and compositions for practicing the same
US10/222,943 US7160997B2 (en) 2002-02-27 2002-08-15 Methods of using FET labeled oligonucleotides that include a 3′→5′ exonuclease resistant quencher domain and compositions for practicing the same

Publications (1)

Publication Number Publication Date
ATE464874T1 true ATE464874T1 (de) 2010-05-15

Family

ID=27753904

Family Applications (2)

Application Number Title Priority Date Filing Date
AT08153863T ATE464874T1 (de) 2002-02-27 2003-02-25 Verfahren zur verwendung von fet-etikettierten oligonukleotiden mit 3',5' exonukleasenresistenter quenchdomäne und zusammensetzungen zur ausübung davon
AT03711238T ATE504284T1 (de) 2002-02-27 2003-02-25 Verfahren zur verwendung von mit fet markierten oligonucleotiden mit einer 3 -5-exonuclease- resistenten quencher-domäne und zusammensetzungen zur durchführung des verfahrens

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT03711238T ATE504284T1 (de) 2002-02-27 2003-02-25 Verfahren zur verwendung von mit fet markierten oligonucleotiden mit einer 3 -5-exonuclease- resistenten quencher-domäne und zusammensetzungen zur durchführung des verfahrens

Country Status (4)

Country Link
US (7) US6818420B2 (de)
EP (1) EP1952792B2 (de)
AT (2) ATE464874T1 (de)
DE (2) DE60332292D1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7019129B1 (en) * 2000-05-09 2006-03-28 Biosearch Technologies, Inc. Dark quenchers for donor-acceptor energy transfer
US6818420B2 (en) * 2002-02-27 2004-11-16 Biosource International, Inc. Methods of using FET labeled oligonucleotides that include a 3′-5′ exonuclease resistant quencher domain and compositions for practicing the same
EP1485056B1 (de) * 2002-02-27 2011-04-06 Life Technologies Corporation Verfahren zur verwendung von mit fet markierten oligonucleotiden mit einer 3 -5-exonuclease-resistenten quencher-domäne und zusammensetzungen zur durchführung des verfahrens
US7365176B2 (en) * 2002-09-26 2008-04-29 Mayo Foundation For Medical Education And Research Detection of Epstein-Barr virus
US20040235032A1 (en) * 2003-05-19 2004-11-25 Canon Kabushiki Kaisha PCR amplification method, PCR primer set, PCR amplification product, and method for detection of nucleic acid using the amplification method
EP1502958A1 (de) * 2003-08-01 2005-02-02 Roche Diagnostics GmbH Neues Format zur Detektion von Heissstart- und Echtzeit-Polymerasekettenreaktion
NZ580169A (en) * 2003-10-23 2011-04-29 Illumigen Biosciences Inc Detection of mutations in a gene associated with resistance to viral infection, OAS1 (SEQ ID NO:48)
CN1910293B (zh) * 2003-10-23 2011-04-13 伊洛默格生物科学公司 检测与抗病毒感染性有关的基因oas1中的突变的方法
US20050250134A1 (en) * 2004-03-02 2005-11-10 Dawei Sheng Fluorescent energy transfer labeled nucleic acid substrates and methods of use thereof
JP4972541B2 (ja) 2004-04-01 2012-07-11 バイオ−ラッド ラボラトリーズ インコーポレーティッド 標識されたプローブおよび３’→５’エキソヌクレアーゼ活性を用いた定量的増幅方法
CA2570693A1 (en) * 2004-06-17 2006-01-26 Wyeth Processes for preparing gonadotropin releasing hormone receptor antagonists
US7696210B2 (en) * 2004-06-17 2010-04-13 Wyeth Gonadotropin releasing hormone receptor antagonists
US7635598B2 (en) * 2004-07-08 2009-12-22 Biosearch Technologies, Inc. Inducible fluorescence assay
MX2007005765A (es) * 2004-11-23 2007-07-19 Wyeth Corp Antagonistas del receptor de la hormona que libera gonadotropina.
US7582634B2 (en) 2005-02-18 2009-09-01 Wyeth 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US7534796B2 (en) * 2005-02-18 2009-05-19 Wyeth Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor
US7538113B2 (en) * 2005-02-18 2009-05-26 Wyeth 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US20060189619A1 (en) * 2005-02-24 2006-08-24 Wyeth 3-({4-[2-(4-Tert-butylphenyl)-1h-benzimidazol-4-yl]piperazin-1-yl}methyl)pyrido[2,3-b]]pyrazi ne compounds
UA95446C2 (ru) * 2005-05-04 2011-08-10 Іллюміджен Байосайєнсіз, Інк. Мутаци в генах oas1
US7531542B2 (en) * 2005-05-18 2009-05-12 Wyeth Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor
US7582636B2 (en) * 2005-05-26 2009-09-01 Wyeth Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor
WO2007056312A2 (en) * 2005-11-07 2007-05-18 Clontech Laboratories, Inc. Universal reporter tag for nucleozyme assays
US8314215B2 (en) * 2006-08-04 2012-11-20 The Board Of Trustees Of The Leland Stanford Junior University Mild chemically cleavable linker system
SI2757091T1 (en) * 2008-04-01 2018-01-31 Biosearch Technologies, Inc. Stabilized nucleic acid black gas-fluorofor probe
KR20110008312A (ko) 2008-05-06 2011-01-26 메타볼릭스 인코포레이티드 생분합성 폴리에스테르 블렌드
US9534255B2 (en) * 2008-12-17 2017-01-03 Life Technologies Corporation Methods, compositions, and kits for detecting allelic variants
EP3249053A1 (de) 2009-03-27 2017-11-29 Life Technologies Corporation Verfahren, zusammensetzungen und kits für den nachweis von allelen varianten
KR20110050327A (ko) * 2009-11-07 2011-05-13 주식회사 씨젠 Ｔｈｄ 프라이머 타겟 검출
WO2011078441A1 (en) * 2009-12-21 2011-06-30 Seegene, Inc. Tsg primer target detection
KR20120042100A (ko) * 2010-10-22 2012-05-03 주식회사 씨젠 이중표지 고정화 프로브를 이용한 고상에서의 타겟 핵산서열 검출
CN109054254B (zh) 2012-08-17 2021-02-02 Cj第一制糖株式会社 用于聚合物共混物的生物基橡胶改性剂
US10669417B2 (en) 2013-05-30 2020-06-02 Cj Cheiljedang Corporation Recyclate blends
NL2012570B1 (nl) * 2014-04-04 2016-03-08 Sparkle Innovations B V Inrichting en werkwijze voor het druppel-voor-druppel toedienen van een vloeistof.
US9724464B2 (en) * 2014-06-30 2017-08-08 Carefusion 303, Inc. Passive restart Y-site
CN104569599B (zh) * 2015-01-09 2017-10-31 杭州电子科技大学 一种电子标签电阻在线检测电路
US10814006B2 (en) 2015-07-14 2020-10-27 University Of Iowa Research Foundation Fluorescent prodrugs
US11028431B2 (en) * 2015-09-22 2021-06-08 Biocartis, Nv Detection of short homopolymeric repeats
US10337051B2 (en) 2016-06-16 2019-07-02 The Regents Of The University Of California Methods and compositions for detecting a target RNA
WO2020028729A1 (en) 2018-08-01 2020-02-06 Mammoth Biosciences, Inc. Programmable nuclease compositions and methods of use thereof
WO2020142754A2 (en) 2019-01-04 2020-07-09 Mammoth Biosciences, Inc. Programmable nuclease improvements and compositions and methods for nucleic acid amplification and detection
EP4219700A1 (de) 2019-03-07 2023-08-02 The Regents of the University of California Crispr-cas-effektorpolypeptide und verfahren zur verwendung davon
WO2021240443A1 (en) 2020-05-27 2021-12-02 King Abdullah University Of Science And Technology Iscan: an rt-lamp-coupled crispr-cas module for rapid, sensitive detection of sars-cov-2
WO2023023673A2 (en) 2021-08-20 2023-02-23 Kasa Bio, L.L.C. Compositions and methods for multiplex detection of mirna and other polynucelotides

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8A (en) * 1836-08-10 T Blanchard Machine for cutting scores around ships' tackle blocks and dead eyes
US4743535A (en) 1984-11-07 1988-05-10 Miles Inc. Hybridization assay employing labeled probe and anti-hybrid
EP0187332B1 (de) 1985-01-10 1989-02-01 Molecular Diagnostics, Inc. Photochemisches Verfahren zum Markieren von Nucleinsäuren zum Nachweis in Hybridisationsproben
US4794073A (en) * 1985-07-10 1988-12-27 Molecular Diagnostics, Inc. Detection of nucleic acid hybrids by prolonged chemiluminescence
US5824796A (en) 1988-09-28 1998-10-20 Epoch Pharmaceuticals, Inc. Cross-linking oligonucleotides
US5763162A (en) * 1990-03-14 1998-06-09 The Regents Of University Of California Multichromophore fluorescent DNA intercalation complexes
US5177196A (en) * 1990-08-16 1993-01-05 Microprobe Corporation Oligo (α-arabinofuranosyl nucleotides) and α-arabinofuranosyl precursors thereof
KR100236506B1 (ko) * 1990-11-29 2000-01-15 퍼킨-엘머시터스인스트루먼츠 폴리머라제 연쇄 반응 수행 장치
US6329346B1 (en) 1991-05-25 2001-12-11 Roche Diagnostics Gmbh Oligo-2′-deoxynucleotides and their use as pharmaceutical agents with antiviral activity
US5419966A (en) 1991-06-10 1995-05-30 Microprobe Corporation Solid support for synthesis of 3'-tailed oligonucleotides
CA2074214C (en) * 1991-07-23 2000-02-22 Will Bloch Improvements in the in situ pcr
DE4140463A1 (de) 1991-12-09 1993-06-17 Boehringer Mannheim Gmbh 2'-desoxy-isoguanosin, dessen isostere analoge sowie anwendung derselben
US5538848A (en) * 1994-11-16 1996-07-23 Applied Biosystems Division, Perkin-Elmer Corp. Method for detecting nucleic acid amplification using self-quenching fluorescence probe
US5840493A (en) * 1994-03-30 1998-11-24 Mitokor Mitochondrial DNA mutations that segregate with late onset diabetes mellitus
US5801155A (en) * 1995-04-03 1998-09-01 Epoch Pharmaceuticals, Inc. Covalently linked oligonucleotide minor grove binder conjugates
US6312894B1 (en) 1995-04-03 2001-11-06 Epoch Pharmaceuticals, Inc. Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
JP4040087B2 (ja) * 1995-05-05 2008-01-30 アプレラ コーポレイション Ｐｃｒ増幅とハイブリダイゼーションプロービングアッセイとを組み合わせた方法およびそのための試薬
US6964861B1 (en) * 1998-11-13 2005-11-15 Invitrogen Corporation Enhanced in vitro recombinational cloning of using ribosomal proteins
PT937098E (pt) * 1995-06-07 2002-12-31 Invitrogen Corp Clonagem recombinatoria in vitro utilizando locais de recombinacao modificados
US5612473A (en) * 1996-01-16 1997-03-18 Gull Laboratories Methods, kits and solutions for preparing sample material for nucleic acid amplification
US5801146A (en) * 1996-05-03 1998-09-01 Abbott Laboratories Compound and method for inhibiting angiogenesis
US5955590A (en) * 1996-07-15 1999-09-21 Worcester Foundation For Biomedical Research Conjugates of minor groove DNA binders with antisense oligonucleotides
US5866336A (en) * 1996-07-16 1999-02-02 Oncor, Inc. Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon
US6117635A (en) * 1996-07-16 2000-09-12 Intergen Company Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon
US5846729A (en) 1997-02-27 1998-12-08 Lorne Park Research, Inc. Assaying nucleotides in solution using a fluorescent intensity quenching effect
DE19720839B4 (de) 1997-05-17 2007-08-16 Dirk Dr. Schindelhauer Baukastenprinzip-Technologie zur Herstellung von langen, exakten DNA-Konstrukten in vitro, insbesondere für die Herstellung von Konstrukten zur Erzeugung von künstlichen Chromosomen (MAC, mammalian artificial chromosome) aus zwei stabil klonierten DNA-Komponenten und der ditelomerische Vektor-Prototyp PTAT
CN100342008C (zh) * 1997-10-24 2007-10-10 茵维特罗根公司 利用具重组位点的核酸进行重组克隆
JP4206154B2 (ja) 1997-11-13 2009-01-07 大日本住友製薬株式会社 変異型ｌｏｘＰ配列とその応用
US5989823A (en) * 1998-09-18 1999-11-23 Nexstar Pharmaceuticals, Inc. Homogeneous detection of a target through nucleic acid ligand-ligand beacon interaction
EP0930370B1 (de) * 1997-12-15 2007-08-08 CSL Behring GmbH Markierter Primer, geeignet für die Detektion von Nukleinsäuren
US6127121A (en) 1998-04-03 2000-10-03 Epoch Pharmaceuticals, Inc. Oligonucleotides containing pyrazolo[3,4-D]pyrimidines for hybridization and mismatch discrimination
US6683173B2 (en) * 1998-04-03 2004-01-27 Epoch Biosciences, Inc. Tm leveling methods
GB9812768D0 (en) * 1998-06-13 1998-08-12 Zeneca Ltd Methods
US6072046A (en) * 1998-08-26 2000-06-06 Epoch Pharmaceuticals, Inc. Diaziridinyl-aryl and bis-[di(chloroethyl)amino]-aryl oligonucleotide conjugates and reagents for making the same
US6432642B1 (en) 1999-01-15 2002-08-13 Pe Corporation (Ny) Binary probe and clamp composition and methods for a target hybridization detection
WO2000052027A1 (en) 1999-03-02 2000-09-08 Invitrogen Corporation Compositions and methods for use in recombinational cloning of nucleic acids
WO2000075378A1 (en) 1999-06-09 2000-12-14 Biosearch Technologies, Inc. Fluorescence energy transfer probes with stabilized conformations
US6660845B1 (en) * 1999-11-23 2003-12-09 Epoch Biosciences, Inc. Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof
US20040081959A9 (en) 1999-12-08 2004-04-29 Epoch Biosciences, Inc. Fluorescent quenching detection reagents and methods
US6727356B1 (en) * 1999-12-08 2004-04-27 Epoch Pharmaceuticals, Inc. Fluorescent quenching detection reagents and methods
AU785483B2 (en) * 1999-12-10 2007-09-20 Invitrogen Corporation Use of multiple recombination sites with unique specificity in recombinational cloning
EP1995330A1 (de) 2000-03-01 2008-11-26 Epoch Biosciences, Inc. Modifizierte Oligonukleotide zur Erkennung von Fehlanpassungen
DE60138952D1 (de) * 2000-03-31 2011-04-28 Millenium Pharmaceuticals Inc 16836, ein mitglied der humanen phospholipase c familie und seine verwendungen
US7019129B1 (en) 2000-05-09 2006-03-28 Biosearch Technologies, Inc. Dark quenchers for donor-acceptor energy transfer
EP1275735A1 (de) 2001-07-11 2003-01-15 Roche Diagnostics GmbH Zusammensetzung und Methode zur 'Hot start' Nukleinsäureamplifizierung
PT1421200E (pt) * 2001-08-23 2007-02-28 Merck & Co Inc Ensaios de pcr multiplex fluorescente para hpv usando múltiplos fluoróforos
EP1442142A4 (de) 2001-10-19 2006-11-15 Proligo Llc Nukleinsäuresonden und verfahren zum nachweis und zur quantifizierung von nukleinsäureanalyten
EP1485056B1 (de) 2002-02-27 2011-04-06 Life Technologies Corporation Verfahren zur verwendung von mit fet markierten oligonucleotiden mit einer 3 -5-exonuclease-resistenten quencher-domäne und zusammensetzungen zur durchführung des verfahrens
US6818420B2 (en) 2002-02-27 2004-11-16 Biosource International, Inc. Methods of using FET labeled oligonucleotides that include a 3′-5′ exonuclease resistant quencher domain and compositions for practicing the same

Also Published As

Publication number Publication date
DE60336639D1 (de) 2011-05-19
US9410187B2 (en) 2016-08-09
US6818420B2 (en) 2004-11-16
US20110020812A1 (en) 2011-01-27
US20090081676A1 (en) 2009-03-26
US8822673B2 (en) 2014-09-02
US20030165920A1 (en) 2003-09-04
EP1952792B2 (de) 2019-01-16
US20030162184A1 (en) 2003-08-28
EP1952792A1 (de) 2008-08-06
US20150072342A1 (en) 2015-03-12
US7754453B2 (en) 2010-07-13
US20120245334A1 (en) 2012-09-27
ATE504284T1 (de) 2011-04-15
US20170029874A1 (en) 2017-02-02
US8088583B2 (en) 2012-01-03
US7160997B2 (en) 2007-01-09
EP1952792B1 (de) 2010-04-21
DE60332292D1 (de) 2010-06-02

Similar Documents

Publication Publication Date Title
ATE464874T1 (de) Verfahren zur verwendung von fet-etikettierten oligonukleotiden mit 3',5' exonukleasenresistenter quenchdomäne und zusammensetzungen zur ausübung davon
ATE557083T1 (de) Thermostabiler oder thermoactiver dna-polymerase mit abgeschwächter 3'-5' exonukleaseaktivität
ATE328115T1 (de) Multiplex genotypisierung unter verwendung von fluoreszenzmarkierten hybridisierungssonden
ATE364718T1 (de) Verfahren zur vervielfältigung von nukleinsäure
WO2005089508A3 (en) Dna sequence detection by limited primer extension
DE69729122D1 (de) KüNSTLICHE FEHLHYBRIDISIERUNG
ATE414096T1 (de) Verfahren zum nachweis und zur quantifizierung von analyten in komplexen mischungen
DE69638318D1 (de) Nukleinsäureliganden, die an DNA-Polymerasen binden und diese inhibieren
BR0308134A (pt) análise rápida das variações em um genoma
WO2003072051A3 (en) Methods of using fet labeled oligonucleotides that include a 3' 5' exonuclease resistant quencher domain and compositions for practicing the same
DE69942444D1 (de) Bestimmung des genotyps eines amplifikationsproduktes an mehreren allelen stellen
Doi et al. A new method for ABO genotyping using a multiplex single-base primer extension reaction and its application to forensic casework samples
DE502004004202D1 (de) Verfahren zum nachweis von cytosin-methylierungen in dna
WO2004010101A3 (en) Detection of chemical ligation using fluorescence quenching leaving groups
DE69616102D1 (de) Amplikationsprimern und Nukleinsäuresonden zum Nachweis von Coccidioides immites
ATE331813T1 (de) Verfahren zum nachweis von homo- oder heterozygotie eines organismus unter verwendung markerter primer und rflp
DE502005010036D1 (de) Verfahren zur geno- und pathotypisierung von pseudomonas aeruginosa
ATE440152T1 (de) Verfahren zum nachweis von cytosinmethylierungsmustern mit hoher empfindlichkeit
DK1620568T3 (da) Analyse til allelspecifik mutationspåvisning
ATE414788T1 (de) Verfahren und kit zur tierartspezifischen dna- identifikation in einer probe
DE602005023586D1 (de) Primer- und sondenkonstruktion zur effizienten amplifikation und detektion des 3'-nichttranslatierten bereichs von hcv
Tews et al. Application of the C4'-alkylated deoxyribose primer system (CAPS) in allele-specific real-time PCR for increased selectivity in discrimination of single nucleotide sequence variants
DE50214183D1 (de) Verfahren zum nachweis von in einer polymerase-kettenreaktion amplifizierten nukleinsäuremolekülen
DE60324819D1 (de) Verfahren zur amplifikation von nukleinsäure, kit zur amplifikation von nukleinsäure, verfahren zum nachweis von einzelnukleotid-polymorphismus und reagentienkit zum nachweis von einzelnukleotid-polymorphismus
ATE315103T1 (de) Verfahren zur typisierung des ha-1 nebenhistokompatibilitätsantigens

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties